Zobrazeno 1 - 10
of 25
pro vyhledávání: '"R J A, van Moorselaar"'
Autor:
J. Janssen, F. H. E. Staal, C. L. Brouwer, J. A. Langendijk, I. J. de Jong, R. J. A. van Moorselaar, E. Schuit, J. F. Verzijlbergen, R. J. Smeenk, S. Aluwini
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background More than 60% of oligo-recurrent prostate cancer (PCa) patients treated with metastasis-directed radiotherapy (MDRT) develop biochemical recurrence within 2 years. This recurrence rate emphasises the need for improved treatment an
Externí odkaz:
https://doaj.org/article/55e4ffe7575643bcb0888b739ecc5219
Autor:
H. Yildirim, M. S. Schuurman, C. V. Widdershoven, B. W. Lagerveld, L. van den Brink, A. E. C. Ruiter, H. P. Beerlage, R. J. A. van Moorselaar, N. M. Graafland, A. Bex, K. K. H. Aben, P. J. Zondervan
Publikováno v:
BJUI Compass, 4, 4, pp. 455-463
Contains fulltext : 294289.pdf (Publisher’s version ) (Open Access) OBJECTIVES: To analyse variation in clinical management of cT1 renal cell carcinoma (RCC) in the Netherlands related to surgical hospital volume (HV). MATERIALS AND METHODS: Patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaf135286179e9ae53bb6661a2d9f583
Autor:
J Bosschieter, S Bach, I V Bijnsdorp, L I Segerink, W F Rurup, A P van Splunter, I Bahce, P W Novianti, G Kazemier, R J A van Moorselaar, R D M Steenbergen, J A Nieuwenhuijzen
Publikováno v:
PLoS ONE, Vol 13, Iss 8, p e0200906 (2018)
BACKGROUND:Urine poses an attractive non-invasive means for obtaining liquid biopsies for oncological diagnostics. Especially molecular analysis on urinary DNA is a rapid growing field. However, optimal and practical storage conditions that result in
Externí odkaz:
https://doaj.org/article/7054071756334e0ea56f33bd7106df9c
Autor:
Y J L, Bodar, W I, Luining, B, Keizer, D, Meijer, A, Vellekoop, M, Schaaf, N H, Hendrikse, R J A, Van Moorselaar, D E, Oprea-Lager, A N, Vis
Publikováno v:
Urologic oncology.
Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) is an emerging staging tool for patients with primary high-risk prostate cancer (PCa). Patients with primary metastatic disease are staged using PSMA-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::410f70c9c4d7eefffabdf501ef67df78
https://pubmed.ncbi.nlm.nih.gov/36588019
https://pubmed.ncbi.nlm.nih.gov/36588019
Autor:
P. C. Johannesma, R. J. A. van Moorselaar, S. Horenblas, L. E. van der Kolk, E. Thunnissen, J. H. T. M. van Waesberghe, F. H. Menko, P. E. Postmus
Publikováno v:
Case Reports in Medicine, Vol 2014 (2014)
Birt-Hogg-Dubé (BHD) syndrome is a cancer disorder caused by a pathogenic FLCN mutation characterized by fibrofolliculomas, lung cysts, pneumothorax, benign renal cyst, and renal cell carcinoma (RCC). In this case we describe a patient with bilatera
Externí odkaz:
https://doaj.org/article/7ee9fba051cf4b6785e94fdd83c47525
Autor:
Marinus J, Hagens, H, Veerman, K M, de Ligt, C N, Tillier, P J, van Leeuwen, R J A, van Moorselaar, H G, van der Poel
Publikováno v:
Journal of robotic surgery. 16(2)
The objective is to evaluate the effect of robot-assisted radical prostatectomy (RARP)-related postoperative complications on the 6-month postoperative health-related quality of life (HRQoL). A total of 1008 patients underwent a RARP with or without
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6da43de2a3c32207578310e7e9dde865
https://pubmed.ncbi.nlm.nih.gov/34120255
https://pubmed.ncbi.nlm.nih.gov/34120255
Autor:
H M, Westgeest, M C P, Kuppen, A J M, van den Eertwegh, R, de Wit, A M, Bergman, R J A, van Moorselaar, J L L M, Coenen, A C M, van den Bergh, D M, Somford, N, Mehra, I M, van Oort, K K H, Aben, W R, Gerritsen, C A, Uyl-de Groot
Publikováno v:
Prostate cancer and prostatic diseases. 24(3)
In 2004 docetaxel was the first life-prolonging drug (LPD) registered for metastatic castration-resistant prostate cancer (mCRPC) patients. Between 2011 and 2014 new LPDs for mCRPC (cabazitaxel, abiraterone, enzalutamide, and radium-223) were introdu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::714fe7d207dd872e60a8cbc4144a2c5d
https://pubmed.ncbi.nlm.nih.gov/33746212
https://pubmed.ncbi.nlm.nih.gov/33746212
Autor:
André N, Vis, R J A, van Moorselaar
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 163
The results of a recent randomised phase 3 clinical trial show that the androgen receptor antagonist darolutamide improves metastasis-free survival in men with non-metastatic, castration-resistant prostate cancer, compared with placebo. The trial inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::779e66652b936a7a20dec9f19200c886
https://pubmed.ncbi.nlm.nih.gov/32073798
https://pubmed.ncbi.nlm.nih.gov/32073798
Autor:
R. J. A. van Moorselaar, M. C. C. M. Hulshof, G. J. L. H. van Leenders, C. M. L. van Herpen, H. van Poppel
Publikováno v:
Leerboek oncologie ISBN: 9789036824484
van Moorselaar, R J A, Hulshof, M C C M, Leenders, G J L H, Van Herpen, C & van Poppel, H 2011, Tumoren van de urinewegen . in Leerboek Oncologie . pp. 479-494 .
Leerboek Oncologie, 479-494
STARTPAGE=479;ENDPAGE=494;TITLE=Leerboek Oncologie
Leerboek oncologie ISBN: 9789036804417
Oncologie ISBN: 9789031362318
van Moorselaar, R J A, Hulshof, M C C M, Leenders, G J L H, Van Herpen, C & van Poppel, H 2011, Tumoren van de urinewegen . in Leerboek Oncologie . pp. 479-494 .
Leerboek Oncologie, 479-494
STARTPAGE=479;ENDPAGE=494;TITLE=Leerboek Oncologie
Leerboek oncologie ISBN: 9789036804417
Oncologie ISBN: 9789031362318
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1ba90725a4315efa9897925f7ca17a0
https://doi.org/10.1007/978-90-368-2449-1_27
https://doi.org/10.1007/978-90-368-2449-1_27
Autor:
M C F, Cysouw, B H E, Jansen, M, Yaqub, J, Voortman, A N, Vis, R J A, van Moorselaar, O S, Hoekstra, R, Boellaard, D E, Oprea-Lager
Publikováno v:
Molecular imaging and biology. 22(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ce8a9e2d1f3bf37b6107b03f19a4be73
https://pubmed.ncbi.nlm.nih.gov/31907848
https://pubmed.ncbi.nlm.nih.gov/31907848